RINVOQ upadacitinib 15 mg modified release tablet blister pack

AbbVie Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 7a3463aa23c2ea12
Product Name: RINVOQ upadacitinib 15 mg modified release tablet blister pack
Artg Id: 312687
Artg Name: RINVOQ upadacitinib 15 mg modified release tablet blister pack
Sponsor: AbbVie Pty Ltd
Company Detail Path: /organization/abbvie-pty-ltd
Artg Date: 2020-01-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-01079-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-01075-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

7a3463aa23c2ea12

Type

Standard